PRESS RELEASE Biocon Q4FY24 Revenue at Rs 3,966 Cr, …

PRESS RELEASE Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr FY24 Revenue at Rs 15,621 Cr, Up 35%; EBITDA at …

CouponFollow Extension

35%
OFF

PRESS RELEASE Biocon Q4FY24 Revenue At Rs 3,966 Cr, …

2 weeks from now

PRESS RELEASE Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr FY24 Revenue at Rs 15,621 Cr, Up 35%; EBITDA at …

biocon.com

57%
OFF

Biocon Q4 Net Profit Down 57% To Rs 136 Cr, Revenue At Rs 3,966 Cr

2 weeks from now

May 16, 2024 · Biocon Q4 Net Profit Down 57% to Rs 136 Cr, Revenue at Rs 3,966 Cr. Share on: By ... "Q4FY24 performance was strongly led by Biologics that delivered the promised billion …

rediff.com

57%
OFF

Biocon Q4 Results: Net Profit Drops 57% To Rs 136 Crore

2 weeks from now

May 16, 2024 · The gross R&D spends declined 36% YoY to Rs 228 crore in Q4FY24. Total revenue grew 1% YoY to Rs 3,966 crore. EBITDA for the quarter declined 16% YoY to Rs 964 …

indiatimes.com

57%
OFF

Biocon Q4 Results: Profit Drops 57% To Rs 135 Crore; Revenue Up 4%

2 weeks from now

May 16, 2024 · Biocon Q4FY24 results: The company board has recommended a final dividend at the rate of 10 per cent i.e. Re. 0.50 per equity share. Friday, January 10, ... Net profit rises …

business-standard.com

57%
OFF

Biocon Q4 Results: Net Profit Falls 57% To Rs 136 Crore; Revenue Up …

2 weeks from now

May 16, 2024 · The company reported a 0.94 per cent Y-o-Y growth in net revenue at Rs 3,966 crore, beating analyst estimates of Rs 3,890 crore. The performance in Q4FY24 was driven by …

business-standard.com

57%
OFF

Biocon Q4 Net Profit Falls 57% To Rs 136 Cr; Revenue At Rs 3,966 Cr

2 weeks from now

May 17, 2024 · Biocon said in a statement that total revenue rose marginally to Rs 3,966 crore in the fourth quarter compared with Rs 3,929 crore in the year-ago period.

outlookbusiness.com

57%
OFF

Biocon Q4 Results - Biocon Q4 Earnings News, Biocon Q4 Result …

2 weeks from now

Biocon Q4 Results: Net profit drops 57% to Rs 136 crore. Total revenue grew 1% YoY to Rs 3,966 crore. EBITDA for the quarter declined 16% YoY to Rs 964 crore, representing an …

indiatimes.com

57%
OFF

Biocon Q4 Results: Net Profit Falls 57% To Rs 136 Crore; Revenue At …

2 weeks from now

The company posted a net profit of Rs 313 crore in the January-March quarter of the last fiscal. Total revenue rose marginally to Rs 3,966 crore in the fourth quarter compared with Rs 3,929 …

msn.com

7%
OFF

Biocon Q3FY25 Revenue At Rs 3,856 Cr, Up 7%# EBITDA At Rs 787 …

2 weeks from now

Jan 30, 2025 · Financial Commentary: Q3FY25. Consolidated Total Revenue for Q3FY25 was at Rs 3,856 crore.Reported 7% YoY growth on a like-for-like basis, after adjusting for Branded …

bioconbiologics.com

21%
OFF

Biocon Q4FY22 Revenue At Rs 2,476 Cr, Up 21%; Core EBITDA At …

2 weeks from now

Apr 28, 2022 · FY22 Revenue at Rs 8,397 Cr, Up 14%; Core EBITDA Up 18% at Rs 2,669 Cr; PBT ... Biocon Biologics Q4FY22. Revenue for Q4FY22 stood at Rs 982 Crore, ... Download …

bioconbiologics.com

59%
OFF

Biocon Q4FY23 Revenue At Rs 3,929 Cr, Up 59%; Biosimilars Up …

2 weeks from now

May 23, 2023 · BIOSIMILARS: Biocon Biologics Limited (BBL) Q4FY23 revenue at Rs 2,102 Crore, up 114% (YoY) from Rs 982 Crore in Q4FY22. FY23 revenue at Rs 5,584 Crore, up …

biocon.com

59%
OFF

Biocon Q1FY24 Revenue At Rs 3,516 Cr, Up 59%;

2 weeks from now

PRESS RELEASE Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% EBITDA at Rs 808 Cr, Up 69%; Core EBITDA at Rs 936 Cr, Up …

biocon.com

FAQs about PRESS RELEASE Biocon Q4FY24 Revenue at Rs 3,966 Cr, … Coupon?

What was Biocon's revenue in Q1FY22?

Biocon's revenue in Q1FY22 was Rs 1,808 Cr, up 6%. EBITDA was Rs 437 Cr; Biosimilars generated Rs 758 Cr, up 10%; Research Services contributed Rs 595 Cr, up 41%. ...

What were Biocon's Q2FY21 financial results?

Biocon's Q2FY21 financial results: Revenue at Rs 1,760 Cr, Up 10%. EBITDA at Rs 407 Cr. Net Profit (before exceptional item & discontinuing operations) at Rs 174 Cr. Generics revenue was Rs 599 Cr, Up 8%. Biosimilars revenue was Rs 676 Cr, Up 11%. Research Services revenue was Rs 520 Cr, Up 12%. ...

How did Biocon perform in q4fy24?

The gross R&D spends declined 36% YoY to Rs 228 crore in Q4FY24. Biocon on Thursday posted a 57% year-on-year (YoY) drop in net profit to Rs.136 crore in Q4FY24, dragged by generics and research services, despite growth of biosimilar business. The company reported Rs 313 crore net profit during the corresponding quarter of the previous year. ...

How did Biocon perform in 4th quarter of financial year 2023-24?

Bengaluru-based biopharma firm Biocon reported a 57 per cent year-on-year (Y-o-Y) drop in its consolidated net profit in the fourth quarter of financial year (FY) 2023-24. Consolidated net profit before exceptional items for the fourth quarter of FY24 stood at Rs 144 crore. It was Rs 335 crore in the same quarter of the previous year. ...

How did biologics perform in q4fy24?

This was also way lower than the consensus estimate of Rs 164.3 crore, according to Bloomberg. The company reported a 0.94 per cent Y-o-Y growth in net revenue at Rs 3,966 crore, beating analyst estimates of Rs 3,890 crore. The performance in Q4FY24 was driven by the Biologics segment. ...

What was the profit in Q4 fy24 compared to last year?

The company reported Rs 135.5 crore in profit in Q4 FY24, compared to Rs 313.2 crore during the same period last year. Sequentially, profit fell 79.4 per cent from Rs 660 crore reported in Q3. Revenue from operations, however, rose marginally by 3.7 per cent at Rs 3,917.1 crore, compared to Rs 3,773.9 crore reported in Q4 FY23. ...